These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37310115)

  • 21. Synthesis, preclinical evaluation, and a pilot clinical imaging study of [
    Xie Q; Liu T; Ding J; Zhou N; Meng X; Zhu H; Li N; Yu J; Yang Z
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3129-3140. PubMed ID: 33630145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography imaging of tumor angiogenesis with a 66Ga-labeled monoclonal antibody.
    Engle JW; Hong H; Zhang Y; Valdovinos HF; Myklejord DV; Barnhart TE; Theuer CP; Nickles RJ; Cai W
    Mol Pharm; 2012 May; 9(5):1441-8. PubMed ID: 22519890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and Application of a PD-L1-Targeted Multimodal Diagnostic and Dual-Functional Theranostics Nanoprobe.
    He C; Guo Y; Zhou N; Wang Z; Liu T; Xu X; Wang F; Zhu H; Yang Z; Yang X; Xia L
    Int J Nanomedicine; 2024; 19():5479-5492. PubMed ID: 38863646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.
    Rubins DJ; Meng X; McQuade P; Klimas M; Getty K; Lin SA; Connolly BM; O'Malley SS; Haley H; Purcell M; Gantert L; Holahan M; Lindgren J; Eklund P; Ekblad C; Frejd FY; Hostetler ED; González Trotter DE; Evelhoch JL
    Mol Imaging Biol; 2021 Apr; 23(2):241-249. PubMed ID: 33098025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and Evaluation of [
    Dam JH; Langkjær N; Baun C; Olsen BB; Nielsen AY; Thisgaard H
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical and exploratory human studies of novel
    Wang X; Zhou M; Chen B; Liu H; Fang J; Xiang S; Hu S; Zhang X
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2584-2594. PubMed ID: 35037984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cutting-edge
    Ge S; Jia T; Shi J; Cao J; Sang S; Li J; Zhang B; Deng S
    Bioorg Chem; 2024 Nov; 152():107745. PubMed ID: 39213795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical translational evaluation of Al
    Wang S; Zhou X; Xu X; Ding J; Liu S; Hou X; Li N; Zhu H; Yang Z
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4259-4271. PubMed ID: 34165601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Preclinical Evaluation of a
    Wang T; Xu P; Fang J; Li C; Zeng X; Liu J; Meng L; Zhuang R; Zhang X; Su X; Guo Z
    Mol Pharm; 2023 Feb; 20(2):1015-1024. PubMed ID: 36562303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting and imaging of HER2 overexpression tumor with a new peptide-based
    Biabani Ardakani J; Akhlaghi M; Nikkholgh B; Hosseinimehr SJ
    Bioorg Chem; 2021 Jan; 106():104474. PubMed ID: 33246602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.
    Erdmann S; Niederstadt L; Koziolek EJ; Gómez JDC; Prasad S; Wagener A; von Hacht JL; Reinicke S; Exner S; Bandholtz S; Beindorff N; Brenner W; Grötzinger C
    Theranostics; 2019; 9(22):6719-6733. PubMed ID: 31588246
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice.
    Lang L; Li W; Guo N; Ma Y; Zhu L; Kiesewetter DO; Shen B; Niu G; Chen X
    Bioconjug Chem; 2011 Dec; 22(12):2415-22. PubMed ID: 22026940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Linker Modification on Tumor-to-Kidney Contrast of
    Kuo HT; Pan J; Zhang Z; Lau J; Merkens H; Zhang C; Colpo N; Lin KS; Bénard F
    Mol Pharm; 2018 Aug; 15(8):3502-3511. PubMed ID: 29920108
    [No Abstract]   [Full Text] [Related]  

  • 35. Biological evaluation of a novel stable peptide PET molecular probe [
    Yao B; Wang L; Xie C; Li M; Peng C; Li Z; Lu W; Chen J
    Nucl Med Biol; 2023; 118-119():108330. PubMed ID: 36889247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
    Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
    J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Wu W; Yu F; Zhang P; Bu T; Fu J; Ai S; You Q; Shi L; Shao G; Wang F; Hodolic M; Guo H
    J Nucl Med; 2022 Sep; 63(9):1394-1400. PubMed ID: 35177423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folate-PEG-NOTA-Al
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57.
    Dam JH; Olsen BB; Baun C; Høilund-Carlsen PF; Thisgaard H
    Mol Imaging Biol; 2016 Jun; 18(3):368-76. PubMed ID: 26561028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide.
    Liu Q; Pan D; Cheng C; Zhang A; Ma C; Wang L; Zhang D; Liu H; Jiang H; Wang T; Xu Y; Yang R; Chen F; Yang M; Zuo C
    Nucl Med Biol; 2015 Dec; 42(12):939-44. PubMed ID: 26344861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.